Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
As of today, Amgen(AMGN) shares are valued at $355.93. The company's market cap stands at 191.7B, with a P/E ratio of 24.59 and a dividend yield of 2.8%.
On 2026-04-09, Amgen(AMGN) stock moved within a range of $346.42 to $359.45. With shares now at $355.93, the stock is trading +2.7% above its intraday low and -1.0% below the session's peak.
Trading volume for Amgen(AMGN) stock has reached 2.94M, versus its average volume of 2.48M.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $391.29 and a low of $261.43.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $391.29 and a low of $261.43.
AMGN News
Amgen recently reported positive Phase 3 results for a subcutaneous, on-body injector version of TEPEZZA in moderate-to-severe active Thyroid Eye Disease, showi...
Guggenheim raised the firm’s price target on Amgen (AMGN) to $351 from $347 and keeps a Neutral rating on the shares. The firm is updating its company model ahe...
In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Amgen, with a price target of $309.00. Unlock hedge fund-level data a...
Analyst ratings
51%
of 37 ratingsMore AMGN News
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. Fo...
Amgen has reported positive Phase 3 results for a new subcutaneous, on-body injector formulation of Tepezza for Thyroid Eye Disease. The late stage trial found...
Wedbush analyst Laura Chico lowered the firm’s price target on Viridian Therapeutics (VRDN) to $31 from $37 and keeps an Outperform rating on the shares. The fi...
Bearish flow noted in Amgen (AMGN) with 3,010 puts trading, or 1.5x expected. Most active are May-26 345 puts and Apr-26 320 puts, with total volume in those st...
Amgen (AMGN) announced positive topline results from a Phase 3 trial of tepezza administered by subcutaneous injection via an on-body injector in participants w...
Amgen Inc (AMGN) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.